Form 8-K - Current report:
SEC Accession No. 0001193125-25-108730
Filing Date
2025-05-01
Accepted
2025-05-01 07:08:02
Documents
15
Period of Report
2025-05-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d949495d8k.htm   iXBRL 8-K 25898
2 EX-99.1 d949495dex991.htm EX-99.1 10889
6 GRAPHIC g949495g0331223802921.jpg GRAPHIC 3678
  Complete submission text file 0001193125-25-108730.txt   171805

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rptx-20250501.xsd EX-101.SCH 2511
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20250501_lab.xml EX-101.LAB 18665
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20250501_pre.xml EX-101.PRE 11672
17 EXTRACTED XBRL INSTANCE DOCUMENT d949495d8k_htm.xml XML 3901
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 25899371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)